8-K: Better Choice Company Adjourns Special Meeting Regarding SRx Health Solutions Transaction

Better Choice Company adjourns its special meeting to March 21, 2025, to allow SRx Health Solutions to finalize its shareholder vote and court order for the arrangement transaction and to update shareholders on compliance with NYSE American listing requirements.

Summary

• Better Choice Company adjourned its special meeting, originally scheduled for February 19, 2025, to March 21, 2025.
• The adjournment pertains to all proposals in the proxy statement, including the proposed arrangement transaction with SRx Health Solutions, Inc.
• The reason for the adjournment is to allow SRx to continue pursuing its shareholder vote and obtain the final order from the Ontario Superior Court of Justice, which are required to complete the transaction.
• It also allows the company to update Better Choice shareholders on corporate actions needed to comply with NYSE American listing requirements.
• At the time of adjournment, proxies representing approximately 71% of Better Choice's outstanding common stock had been submitted, constituting a quorum and sufficient votes for approval of all proposals.
• The company plans to file a supplement to the proxy statement with the SEC to provide updated information to stockholders.
• The adjourned Special Meeting will be held via live webcast on March 21, 2025, at 9:00 a.m. Eastern Time.
• The record date for stockholders to vote remains January 21, 2025.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the announcement primarily concerns the procedural matter of adjourning a meeting. While the delay introduces some uncertainty, the high proxy turnout suggests continued shareholder support.

Positives

• A quorum was already achieved with 71% of shares represented by proxies at the time of adjournment, indicating strong shareholder engagement.
• The company is taking steps to ensure compliance with NYSE American listing requirements.

Negatives

• The adjournment of the special meeting introduces uncertainty and delays the finalization of the proposed arrangement transaction with SRx Health Solutions, Inc.

Risks

• The arrangement transaction with SRx Health Solutions is contingent on SRx obtaining its shareholder vote and a final order from the Ontario Superior Court of Justice.
• Failure to comply with NYSE American listing requirements could negatively impact the company.
• Delays in the transaction could affect investor confidence and the company's stock price.

Future Outlook

The company intends to file a supplement to the Proxy Statement and proceed with the Special Meeting on March 21, 2025, pending SRx's shareholder vote and court order.

Industry Context

The pet health and wellness industry is experiencing growth due to increased pet humanization and consumer focus on health and wellness. This transaction could position Better Choice Company to further capitalize on these trends.

Stakeholder Impact

• Shareholders will need to wait longer to see the outcome of the proposed arrangement transaction with SRx Health Solutions.
• The company aims to keep shareholders informed through a supplement to the proxy statement.

Next Steps

• SRx Health Solutions to continue pursuing its shareholder vote and final order from the Ontario Superior Court of Justice.
• Better Choice Company to file a supplement to the proxy statement with the SEC.
• Better Choice Company to hold the adjourned Special Meeting on March 21, 2025.

Key Dates